pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3200 |
Genomic Coordinates | chr22: 30731557 - 30731641 |
Description | Homo sapiens miR-3200 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||
---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3200-3p | ||||||
Sequence | 54| CACCUUGCGCUACUCAGGUCUG |75 | ||||||
Evidence | Experimental | ||||||
Experiments | Illumina | ||||||
SNPs in miRNA |
|
||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RPSA | ||||||||||||||||||||
Synonyms | 37LRP, 67LR, ICAS, LAMBR, LAMR1, LBP, LBP/p40, LRP, LRP/LR, NEM/1CHD4, SA, lamR, p40 | ||||||||||||||||||||
Description | ribosomal protein SA | ||||||||||||||||||||
Transcript | NM_002295 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RPSA | |||||||||||||||||||||
3'UTR of RPSA (miRNA target sites are highlighted) |
>RPSA|NM_002295|3'UTR 1 GCTGTTCTTGCATAGGCTCTTAAGCAGCATGGAAAAATGGTTGATGGAAAATAAACATCAGTTTCTAAAAGTTGTCTTCA 81 TTTAGTTTGCTTTTTACTCCAGATCAGAATACCTGGGATTGCATATCAAAGCATAATAATAAATACATGTCTCGACATGA 161 GTTGTACTTCTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Flp-In T-REx 293-hAGO1 cells |
Location of target site | CDS |
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
35 hsa-miR-3200-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT052815 | CDC37 | cell division cycle 37 | ![]() |
1 | 1 | |||||||
MIRT052816 | ATP6V1E2 | ATPase H+ transporting V1 subunit E2 | ![]() |
1 | 1 | |||||||
MIRT052817 | MCM3AP | minichromosome maintenance complex component 3 associated protein | ![]() |
1 | 1 | |||||||
MIRT052818 | NSUN4 | NOP2/Sun RNA methyltransferase family member 4 | ![]() |
1 | 1 | |||||||
MIRT052819 | EXOC4 | exocyst complex component 4 | ![]() |
1 | 1 | |||||||
MIRT052820 | DDB1 | damage specific DNA binding protein 1 | ![]() |
1 | 1 | |||||||
MIRT052821 | CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | ![]() |
1 | 1 | |||||||
MIRT052822 | RPL23 | ribosomal protein L23 | ![]() |
1 | 1 | |||||||
MIRT052823 | TPT1 | tumor protein, translationally-controlled 1 | ![]() |
1 | 1 | |||||||
MIRT052824 | RPSA | ribosomal protein SA | ![]() |
1 | 1 | |||||||
MIRT052825 | PPIA | peptidylprolyl isomerase A | ![]() |
1 | 1 | |||||||
MIRT052826 | SSRP1 | structure specific recognition protein 1 | ![]() |
1 | 1 | |||||||
MIRT052827 | STX2 | syntaxin 2 | ![]() |
1 | 1 | |||||||
MIRT095464 | PURA | purine rich element binding protein A | ![]() |
![]() |
2 | 4 | ||||||
MIRT325192 | PSAT1 | phosphoserine aminotransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447293 | ZNF562 | zinc finger protein 562 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450360 | GRAMD3 | GRAM domain containing 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT482917 | ZNF845 | zinc finger protein 845 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498302 | DCAF8 | DDB1 and CUL4 associated factor 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500041 | PABPC3 | poly(A) binding protein cytoplasmic 3 | ![]() |
![]() |
2 | 8 | ||||||
MIRT541475 | ARHGAP12 | Rho GTPase activating protein 12 | ![]() |
![]() |
2 | 12 | ||||||
MIRT556269 | MAPK6 | mitogen-activated protein kinase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565440 | SURF4 | surfeit 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573386 | GPR20 | G protein-coupled receptor 20 | ![]() |
![]() |
2 | 2 | ||||||
MIRT627911 | OCIAD2 | OCIA domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633645 | SKAP2 | src kinase associated phosphoprotein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643472 | PDK3 | pyruvate dehydrogenase kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646284 | GALNT2 | polypeptide N-acetylgalactosaminyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647889 | CD55 | CD55 molecule (Cromer blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT664712 | EIF4G3 | eukaryotic translation initiation factor 4 gamma 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668135 | GINS2 | GINS complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686490 | TRIOBP | TRIO and F-actin binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT709525 | IGF2 | insulin like growth factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722252 | NTMT1 | N-terminal Xaa-Pro-Lys N-methyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT755478 | CAMK2A | calcium/calmodulin dependent protein kinase II alpha | 4 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|